Table 1. Presenting features of patients... | American Society of Hematology

Table 1.

Presenting features of patients at diagnosis

				Immunophenotype
Patient	WCC, × 10⁹/L	Ph⁺ metaphases, %	FISH^*BCR/ABL, %	CD34	CD33	CD3	CD19
1	135	100	49	8	56	11	3
2	86	100	ND	11	31	17	5
3	219	100	39	5	46	26	2
4	29	100	ND	7	19	37	4
5	157	78	55	15	29	15	6
6	163	100	ND	9	57	13	4
7	72	100	87	6	39	16	3
8	117	100	ND	13	41	9	4
9	243	100	ND	9	38	24	5
10	213	100	ND	10	32	16	3
11	268	100	ND	13	43	7	5
12	135	100	ND	8	34	14	4
13	97	100	69	9	24	13	2
14	103	86	ND	12	46	19	3
15	167	100	ND	8	37	21	5
16	140	100	74	6	43	17	5
17	121	100	ND	7	49	13	3

				Immunophenotype
Patient	WCC, × 10⁹/L	Ph⁺ metaphases, %	FISH^*BCR/ABL, %	CD34	CD33	CD3	CD19
1	135	100	49	8	56	11	3
2	86	100	ND	11	31	17	5
3	219	100	39	5	46	26	2
4	29	100	ND	7	19	37	4
5	157	78	55	15	29	15	6
6	163	100	ND	9	57	13	4
7	72	100	87	6	39	16	3
8	117	100	ND	13	41	9	4
9	243	100	ND	9	38	24	5
10	213	100	ND	10	32	16	3
11	268	100	ND	13	43	7	5
12	135	100	ND	8	34	14	4
13	97	100	69	9	24	13	2
14	103	86	ND	12	46	19	3
15	167	100	ND	8	37	21	5
16	140	100	74	6	43	17	5
17	121	100	ND	7	49	13	3

WCC indicates white blood cell count; ND, not determined.

At diagnosis.